INTS NASDAQ
Intensity Therapeutics, Inc.
1W: -9.5%
1M: -14.0%
3M: -23.9%
YTD: -66.2%
1Y: -46.6%
3Y: -96.5%
$3.44
+0.23 (+7.17%)
Weekly Expected Move ±7.8%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-07-05
Earliest Filing
2024-07-03
Latest Filing
partner: 2
acquirer: 1
Counterparties (Filed by INTS)
3 relationshipsCompanies named in INTS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for the At The Market Offering Agreement | 2024-07-03 | View |
| The Swiss Group for Cancer Research SAKK | — | partner | Collaboration agreement for INVINCIBLE-4 Study in Europe | 2024-05-10 | View |
| The Benchmark Company, LLC | — | acquirer | Representative of underwriters for the initial public offering | 2023-07-05 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-06-16 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-27 | Earnings Release; Exhibits | View | |
| 2026-03-23 | Other Events; Exhibits | View | |
| 2026-03-06 | Other Events; Financial Statements and Exhibits | View | |
| 2026-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-13 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-12-05 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-12-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-31 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-10-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-09-10 | Other Events | View | |
| 2025-08-12 | Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-18 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-13 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-06-06 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR